Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies프로폴리스, 꿀벌 꿀 및 그 구성 요소는 코로나바이러스 질병 2019(COVID-19)로부터 보호합니다: In Silico, In Vitro 및 임상 연구에 대한 검토Review Published on 2021-02-252022-09-10 Journal: Molecules [Category] MERS, 임상, 치료제, [키워드] ACE-II activities Anti-inflammatory antioxidant Antiviral antiviral drug Antiviral effect Antiviral treatment bee bee honey bee products caffeic acid clinical Combination component Compound coronavirus disease Coronavirus disease 2019 Coronaviruses COVID -19 COVID-19 cytokine Cytokine storm discharge Effect Effects examined exhibited Express fatality flavonoids green Honey hospital hospitalized COVID-19 patient hospitalized COVID-19 patients host cells immune immunomodulatory in silico in vitro inhibit inhibited less Liposome Luteolin main protease molecular docking/biochemical modeling molecular simulations Mortality naringin natural Nigella Sativa non-structural protein non-structural proteins Prophylactic Propolis randomized clinical trials receiving Remdesivir respiratory review rutin SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome spike glycoprotein standard care Symptom the cytokine storm these compound these compounds Treatment treatment for COVID-19 Treatment outcome Trigger Vero E6 VERO E6 cells Viral viral clearance viral replication viral spike viral-host interaction virulence [DOI] 10.3390/molecules26051232 PMC 바로가기 [Article Type] Review
Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detectionSARS-CoV-2 핵산 검출의 음성 전환 시간이 연장된 입원 경증/중증도 COVID-19 환자의 임상 특성Research Article Published on 2021-02-032022-09-10 Journal: BMC Infectious Diseases [Category] MERS, 치료기술, [키워드] 95% CI 95%CI Abnormalities abnormality Analysis analyzed Characteristics Chest CT clinical Clinical characteristics Clinical features clinical manifestation clinical symptom cough COVID-19 COVID-19 patient COVID-19 patients diarrhea Disease progression enrolled erythrocyte expectoration Factor Factors Fever hemoglobin Hospitalized independent laboratory data leucocyte median Multivariate analysis nausea Negative conversion Negative conversion time Patient predict provided Result risk factor Risk factors SARS-CoV-2 SARS-CoV-2 nucleic acid SARS-CoV-2 RNA supplementary material the patient Treatment treatment of COVID-19 Treatment outcome Univariate analysis Viral Viral RNA were used [DOI] 10.1186/s12879-021-05851-z PMC 바로가기 [Article Type] Research Article
Short-term outcomes after Ivor Lewis oesophagectomy for cancer during the COVID-19 pandemicArticle Published on 2021-02-012023-07-12 Journal: Annals of the Royal College of Surgeons of England [Category] SARS, [키워드] COVID-19 oesophageal neoplasms Oesophagectomy Treatment outcome [DOI] 10.1308/rcsann.2020.7002 PMC 바로가기
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysisResearch Article Published on 2021-01-112022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, [키워드] 95% CI Antiviral candidate Clinical outcome conducted controls Coronaviruses COVID-19 COVID-19 patient COVID-19 patients cytokine release discharge disease Efficacy estimate highly pathogenic hospital discharge Human ICU admission indicated infection control interferon interferon treatment investigator janus medRxiv Meta-analysis Mortality non-randomized novel Novel coronavirus pandemic positive Randomized RCT recipient reduced respiratory infection Result risk SARS-CoV-2 searched significantly significantly increased Spread standard treatment supplementary material systematic review therapy These data treated Treatment Treatment outcome trials Type type I interferon viral infection virus while [DOI] 10.1186/s12879-020-05730-z PMC 바로가기 [Article Type] Research Article
Outcomes for patients with COVID-19: known knowns, known unknowns, and unknown unknownsEditorial Published on 2021-01-012023-07-12 Journal: The Medical journal of Australia [Category] SARS, [키워드] COVID-19 intensive care Treatment outcome [DOI] 10.5694/mja2.50890 [Article Type] Editorial
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study중국 뇌졸중 코로나19 환자의 임상적 특징과 치료 결과: 다기관 후향적 연구Multicenter Study Published on 2021-01-012022-09-11 Journal: Phytomedicine : international journal of phytother [Category] 치료법, 치료제, [키워드] addition age analyzed Antibiotics Antiviral treatment blood glucose C-reactive protein Characteristics China Chinese clinical Clinical characteristics Coagulation Coagulation system Complication conducted cough COVID-19 COVID-19 patient COVID-19 patients creatine creatine kinase cured D-dimer discharged duration of hospitalization elevated enrolled epidemiological fatigue Fever fibrinogen Glucose had more higher risk hospital infections Laboratory laboratory findings Laboratory test Lactate lactate dehydrogenase lymphocyte Lymphocytes median Medicine multicenter Neutrophils Novel coronavirus Older older patient older patients outcome outcomes oxygen Patient patients patients died Platelet Platelet count Previous studies previous study receiving reported Research Retrospective study Severe case severe cases Severe patient severe patients significant difference significant differences stroke susceptible Symptom therapeutic Traditional Traditional Chinese medicine Treatment Treatment outcome treatment regimen treatment regimens [DOI] 10.1016/j.phymed.2020.153433 PMC 바로가기 [Article Type] Multicenter Study
Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbiditiesResearch Paper Published on 2020-11-302022-10-28 Journal: Aging (Albany NY) [Category] COVID-19, SARS, [키워드] accompanied aggravate Analysis analyzed Blood Cancer CD4+ T cell clinical coagulation disorders Comorbidities Comorbidity COVID-19 decrease determine diabetes disease erythrocyte sedimentation rate evaluated exacerbate exhibit glucocorticoid Glucocorticoid therapy hypertension hypokalemia IL-6 immunological characteristics immunological function independent indicated Inflammatory Inflammatory cytokines Inflammatory factor information interferon-γ Laboratory Lymphocyte count lymphopenia Patient patients with comorbidity Pneumonia poor prognosis Prognostic factors progression protein level severe COVID-19 severe COVID-19 patient therapy therapy for COVID-19 Treatment outcome underlying disorder Variability [DOI] 10.18632/aging.202172 PMC 바로가기 [Article Type] Research Paper
Activities of Serum Ferritin and Treatment Outcomes Among COVID-19 Patients Treated With Vitamin C and Dexamethasone: An Uncontrolled Single-Center Observational StudyAllergy/Immunology Published on 2020-11-112022-10-31 Journal: Cureus [Category] COVID-19, [키워드] accompanied activity age Computed tomography conducted COVID 19 COVID-19 COVID-19 patient COVID-19 positive patient ct-imaging Cytokine storm Cytokine storm syndrome dependent on Dexamethasone Diagnosis disease severity expired ferritin ferritin level Infection Lungs material outcome Patient polymerase chain reported Result RT-PCR SARS-CoV-2 SARS-CoV-2 infected patient serum Serum ferritin serum ferritin level single-center syndrome the cytokine storm the patient treated Treatment Treatment outcome uncontrolled Vitamin Vitamin C [DOI] 10.7759/cureus.11442 PMC 바로가기 [Article Type] Allergy/Immunology
Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020Article Published on 2020-11-092023-07-12 Journal: Journal of Korean medical science [Category] SARS, [키워드] coronavirus public-private sector partnerships quality indicators SARS virus Treatment outcome [DOI] 10.3346/jkms.2020.35.e388 PMC 바로가기
Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three casesCase report Published on 2020-11-012022-10-05 Journal: Journal of the Formosan Medical Association = Taiw [Category] SARS, 치료법, [키워드] acute respiratory syndrome Antiviral ARDS bronchitis caused clinical Clinical outcome Comorbidities coronavirus COVID pneumonia COVID-19 COVID-19 patient COVID-19 pneumonia patient diabete diagnosed feature female global public health highlight male moderate mortality risk factors Multidisciplinary therapeutic approach novel coronavirus disease pandemic Patient Pneumonia Psychological intervention SARS-CoV-2 Severe case Severe COVID-19 pneumonia Support the patient Therapeutic approach Treatment Treatment outcome [DOI] 10.1016/j.jfma.2020.04.008 [Article Type] Case report